Century Therapeutics

About:

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Website: https://www.centurytx.com

Twitter/X: century_tx

Top Investors: OrbiMed, RA Capital Management, Fidelity, Bristol-Myers Squibb, Marshall Wace

Description:

Century Therapeutics builds an allogeneic iPSC-derived cell therapy platform that integrates gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies with significant unmet medical needs.

Total Funding Amount:

$620M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2018-01-01

Contact Email:

media(AT)centurytx.com

Founders:

Marcela Maus

Number of Employees:

101-250

Last Funding Date:

2024-04-11

IPO Status:

Public

© 2025 bioDAO.ai